Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
11 p, 286.2 KB Long-term safety and efficacy of eculizumab in generalized myasthenia gravis / Muppidi, Srikanth (Stanford University School of Medicine) ; Utsugisawa, Kimiaki (Hanamaki General Hospital) ; Benatar, Michael (University of Miami Miller School of Medicine) ; Murai, Hiroyuki (International University of Health and Welfare) ; Barohn, Richard J. (University of Kansas Medical Center) ; Illa, Isabel (Hospital Universitari Vall d'Hebron) ; Jacob, Saiju (University Hospital Birmingham) ; Vissing, John (University of Copenhagen) ; Burns, Ted M. (University of Virginia Health System) ; Kissel, John T. (The Ohio State University) ; Nowak, Richard J. (Yale University) ; Andersen, Henning (Aarhus University Hospital (Aarhus, Dinamarca)) ; Casasnovas, Carlos (Hospital Universitari de Bellvitge) ; de Bleecker, Jan L. (Universitair Ziekenhuis Gent) ; Vu, Tuan H. (University of South Florida) ; Mantegazza, Renato (IRCSS) ; O'Brien, Fanny L. (Alexion Pharmaceuticals) ; Wang, Jing Jing (Alexion Pharmaceuticals) ; Fujita, Kenji P. (Alexion Pharmaceuticals) ; Howard, James F. (University of North Carolina)
Introduction : Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of REGAIN, evaluating eculizumab's long-term safety and efficacy. [...]
2019 - 10.1002/mus.26447
Muscle & nerve, Vol. 60 (march 2019) , p. 14-24  
2.
12 p, 385.6 KB Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis / Lee, Jae-Yun (Yale School of Medicine. Department of Neurology) ; Stathopoulos, Panos (Yale School of Medicine. Department of Neurology) ; Gupta, Sasha (Yale School of Medicine. Department of Neurology) ; Bannock, Jason M. (Yale School of Medicine. Department of Immunobiology) ; Barohn, Richard J. (University of Kansas Medical Center. Department of Neurology) ; Cotzomi, Elizabeth (Yale School of Medicine. Department of Neurology) ; Dimachkie, Mazen M. (University of Kansas Medical Center. Department of Neurology) ; Jacobson, Leslie (John Radcliffe Hospital (Oxford, Regne Unit)) ; Lee, Casey S. (Yale School of Medicine. Department of Neurology) ; Morbach, Henner (Yale School of Medicine. Department of Immunobiology) ; Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Shan, Jing-Li (Yale School of Medicine. Department of Neurology) ; Vander Heiden, Jason A. (Yale University. Interdepartmental Program in Computational Biology and Bioinformatics) ; Waters, Patrick (John Radcliffe Hospital (Oxford, Regne Unit)) ; Vincent, Angela (John Radcliffe Hospital (Oxford, Regne Unit)) ; Nowak, Richard J. (Yale School of Medicine. Department of Neurology) ; O'Connor, Kevin C. (Yale School of Medicine. Department of Neurology) ; Universitat Autònoma de Barcelona
Myasthenia gravis () is an autoimmune condition in which neurotransmission is impaired by binding of autoantibodies to acetylcholine receptors (hR) or, in a minority of patients, to muscle specific kinase (Mu). [...]
2016 - 10.1002/acn3.311
Annals of Clinical and Translational Neurology, Vol. 3, Issue 6 (June 2016) , p. 443-454  

Vegeu també: autors amb noms similars
1 Barohn, R.J.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.